Avanos Medical (AVNS) Non-Current Debt (2014 - 2022)

Avanos Medical has disclosed Non-Current Debt across 8 years of filings, most recently posting $226.3 million for Q4 2022.

• Non-Current Debt for Q4 2022 came in at $226.3 million, up 74.08% year-over-year; the trailing twelve-month figure through Dec 2022 was $226.3 million (up 74.08% YoY), and the FY2022 annual result was $226.3 million, up 74.08% from the prior year.
• Non-Current Debt came in at $226.3 million for Q4 2022 at Avanos Medical, up from $130.0 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $542.0 million in Q1 2018 to a low of $130.0 million in Q4 2021.
• The 4-year median for Non-Current Debt is $247.6 million (2018), against an average of $269.9 million.
• Across the five-year window, Non-Current Debt sank 57.34% in 2018 and soared 74.08% in 2022, its largest moves.
• Avanos Medical's Non-Current Debt stood at $247.7 million in 2018, then grew by 0.16% to $248.1 million in 2019, then plunged by 47.6% to $130.0 million in 2021, then jumped by 74.08% to $226.3 million in 2022.
• The last three Non-Current Debt figures came in at $226.3 million (Q4 2022), $130.0 million (Q4 2021), and $248.1 million (Q4 2019), per Business Quant data.